6533b823fe1ef96bd127f4ec
RESEARCH PRODUCT
Benzodiazepine receptor binding: the interactions of some non-benzodiazepine drugs with specific [3H] diazepam binding to rat brain synaptosomal membranes.
Uwe WollertUwe SchläferWalter E. Müllersubject
Malemedicine.drug_classReceptors DrugPharmacologyIn Vitro TechniquesAnxiolyticBinding Competitivechemistry.chemical_compoundmedicineAnimalsDrug InteractionsBenzodiazepine receptor bindingPharmacologyBenzodiazepineDiazepam bindingDiazepamMembranesGABAA receptorBrainGeneral MedicineRatsBaclofenAnalepticchemistryBenzoctaminemedicine.drugSynaptosomesdescription
The interaction of several non-benzodiazepine drugs with [3H] diazepam binding to benzodiazepine receptors in rat brain synaptosomal membranes was investigated. Baclofen, benzoctamine, hydroxyzine, chlorpromazine, haloperidol, imipramine, and amitriptyline displace specific [3H] diazepam binding, but the concentrations needed are too high to explain pharmacological effects of these drugs by an interaction with benzodiazepine receptors. The most potent non-benzodiazepine drug for inhibiting specific [3H] diazepam binding was methaqualone (IC50 value of 150 micrometer). It is suggested that interactions with benzodiazepine receptors may account for the anxiolytic and anticonvulsive side effects of this drug. The analeptic drug pentylenetetrazole interacts with benzodiazepine receptor binding with an IC50 value of about 1 mM, which is possibly too high to explain its convulsive properties by an antagonism at the benzodiazepine receptor.
year | journal | country | edition | language |
---|---|---|---|---|
1978-10-01 | Naunyn-Schmiedeberg's archives of pharmacology |